Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00105911 · ClinicalTrials.gov registry record · NA
A Cognitive-Behavioral Intervention for Depression and Anxiety in COPD
A NA study of Anxiety Disorders and Pulmonary Disease, Chronic Obstructive, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 222
- Enrollment target
- 1
- Study location
NCT00105911: Completed NA study of Anxiety Disorders and Pulmonary Disease, Chronic Obstructive, sponsored by US Department of Veterans Affairs.
NCT00105911 is a NA study of Anxiety Disorders and Pulmonary Disease, Chronic Obstructive that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 222 participants, below the 1,137-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00105911, a NA study of Anxiety Disorders and Pulmonary Disease, Chronic Obstructive, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 222 participants
- Enrollment target
- 1
- Study location
Study Summary
The literature and our preliminary studies found that in COPD patients, psychosocial factors affect quality of life (QOL) and functioning more than would be expected given the severity of their disease. To improve QOL and functioning in the approximately 50% of COPD patients with significant anxiety and/or depressive symptoms, interventions are needed. Much research documents the utility of cognitive behavioral therapy (CBT) in treating depression and anxiety, showing it to have promise as a self-management intervention to improve QOL in COPD patients.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
Study Locations (1)
Texas
- Michael E. DeBakey VA Medical Center, Houston, TX - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2002-07 |
| Est. Completion | 2005-06 |
| Phase | NA |
What the finished NCT00105911 record still lists
NCT00105911 is an interventional study that assigns participants to a tested intervention. The registered 222 participants enrollment target is mid-sized for trials with a published cap, below the 1,137-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (80% lower).
The record links to 3 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.
NCT00105911 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00105911 about?
NCT00105911 is a clinical study titled "A Cognitive-Behavioral Intervention for Depression and Anxiety in COPD". The literature and our preliminary studies found that in COPD patients, psychosocial factors affect quality of life (QOL) and functioning more than would be expected given the severity of their disease. To improve QOL and functioning in the approximately 50% of COPD patients with significant anxiety...
What is the current status of trial NCT00105911?
This trial is currently completed. It is a NA study. The enrollment target is 222 participants. The study started on 2002-07. Estimated completion is 2005-06.
What conditions does trial NCT00105911 study?
This clinical trial studies the following conditions: Anxiety Disorders, Pulmonary Disease, Chronic Obstructive, Depressive Disorders.
What interventions are being tested in trial NCT00105911?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00105911?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00105911 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00105911's enrollment target sits among peer trials
222 23rd of 84 higher than 62 of 84 other Anxiety Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04939610 · 222 participants · Phase 1
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- NCT05424783 · 222 participants
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)
- NCT05568264 · 222 participants · NA
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
- NCT05605574 · 222 participants · NA
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia